e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Cellular and molecular aspects of pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Chemokine (C-C motif) ligand (CCL)-2 regulation by IL-13 in pulmonary arterial hypertension (PAH)
A. Zakrzewicz, M. Hecker, M. George, J. Wilhelm, W. Seeger, H. Ghofrani, O. Eickelberg (Giessen, Germany)
Source:
Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension
Session:
Cellular and molecular aspects of pulmonary hypertension
Session type:
Electronic Poster Discussion
Number:
489
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Zakrzewicz, M. Hecker, M. George, J. Wilhelm, W. Seeger, H. Ghofrani, O. Eickelberg (Giessen, Germany). Chemokine (C-C motif) ligand (CCL)-2 regulation by IL-13 in pulmonary arterial hypertension (PAH). Eur Respir J 2007; 30: Suppl. 51, 489
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Fractalkine and its receptor (CX3CR1) in primary pulmonary hypertension (PPH)
Source: Eur Respir J 2001; 18: Suppl. 33, 2s
Year: 2001
Idiopathic pulmonary fibrosis fibroblasts migrate and proliferate to CC chemokine ligand 21
Source: Eur Respir J 2007; 29: 1082-1093
Year: 2007
The interleukin 13 receptor system is altered in pulmonary arterial hypertension
Source: Annual Congress 2006 - Lung vascular and parenchymal remodeling
Year: 2006
Deletion in macrophage chemokine receptor gene (CCR5) in children with bronchial asthma (BA)
Source: Eur Respir J 2001; 18: Suppl. 33, 450s
Year: 2001
C-C chemokine receptor 2 gene polymorphism V64I and C-C chemokine receptor 5 gene polymorphism Δ32 in pulmonary sarcoidosis patients
Source: Eur Respir J 2006; 28: Suppl. 50, 520s
Year: 2006
A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation
Source: Eur Respir J 2008; 31: 783-789
Year: 2008
A possible role for toll-like receptor (TLR) 5 in fibrotic pulmonary sarcoidosis
Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis
Year: 2008
T-helper cell type-1 transcription factor T-bet is upregulated in pulmonary sarcoidosis
Source: Eur Respir J 2011; 38: 1136-1144
Year: 2011
Arterial concentration of macrophage migration inhibitory factor (MIF) increases with exercise in patients with pulmonary hypertension (PH)
Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Year: 2010
Enhanced expression of IL-18 receptor but not soluble form of IL18R in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2011 - COPD: clinical studies and animal cell models
Year: 2011
Expression on peripheral blood (PB) and induced sputum (IS) neutrophils (N) of the IL-8 receptors CXCR1 and CXCR2. Comparison between neutrophilic asthma and COPD
Source: Annual Congress 2003 - From gene to breath analysis in airway disorders
Year: 2003
CCR5 expression and CC chemokine levels in idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 25: 701-707
Year: 2005
LSC Abstract – Toll-like receptor 4 (TLR4) in idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2015 – IPF pathogenesis
Year: 2015
CC and C chemokine expression in pulmonary sarcoidosis
Source: Eur Respir J 2002; 20: 1206-1212
Year: 2002
Elevated CCL2 responses in COPD and attenuation by selective chemokine receptor antagonists
Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Year: 2015
Upregulation of interleukin 13 receptor alpha 2 (IL-13RA2) expression in idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 267s
Year: 2005
C-C chemokine receptor 2 gene polymorphism V64I and CCR2 expression on T lymphocytes in pulmonary sarcoidosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 268s
Year: 2005
Monocyte chemotactic protein-1 (MCP-1) synthesis and function in pulmonary artery smooth muscle cells (PA-SMCs) from patients with idiopathic pulmonary hypertension (IPH)
Source: Eur Respir J 2004; 24: Suppl. 48, 436s
Year: 2004
Enhanced expression of proinflammatory cytokine (IL-18) and its receptor in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 551s
Year: 2006
CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis
Source: Eur Respir J 2009; 34: 676
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept